DNA Modifications by Novel Antitumor Platinum Drugs
Publisher
Springer Netherlands
Reference117 articles.
1. Aebi, S., Fink, D., Gordon, R., Kim, H.K., Zheng, H., Fink, J.L. and Howell, S.B. (1997) Resistance to cytotoxic drugs in DNA mismatch rcpair-defieient cells. Clin. Cancer Res. 3, 1763–1767. 2. Allday, M.J., lnman, G.J., Crawford, D.H. and Farrell, P.J. (1995) DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective, EMBO J. 14, 4994–5005. 3. Anin, M.F. and Leng, M. (1990) Distortions induced in double-stranded oligonucleorides by the binding of cis-diamminedichloroplatinum(II) or trans-diamminedichloroplatinum(II) to the d(GTG) sequence, Nucleic Acids Res. 18, 4395–4400. 4. Asahina, H., Kuraoka, I., Shirakawa, M., Morita, E., Miura, N., Miyamoto, I., Ohtsuka, E., Okada, Y. and Tanaka, K. (1994) The XPA protein is a zinc metalloprotein with an abilito to recognize various kinds of DNA-damage, Mutat. Res. 315, 229–237. 5. Balcarova, Z. and Brabec, V. (1986) DNA modified by platinum derivatives cannot adopt the A-form, Biochim. Biophys. Acta 867, 31–35.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|